Regenerative Medical Technology (RMTG) Assets (2017 - 2026)
Regenerative Medical Technology (RMTG) posted quarterly Assets of $5.0 million for Q1 2026, up 25.84% year-over-year from $4.0 million in Q1 2025, and up 11.6% quarter-over-quarter from $4.5 million in Q4 2025.
Regenerative Medical Technology (RMTG) Assets (2017 - 2026) Analysis & Trends
Regenerative Medical Technology's Assets history runs 10 years deep, the most recent figure standing at $5.0 million for Q1 2026.
- In Q1 2026, Assets rose 25.84% year-over-year to $5.0 million; the TTM figure through Mar 2026 stood at $5.0 million (up 25.84% YoY), while the FY2025 annual figure was $4.5 million, up 17.46% from the prior year.
- Assets for Q1 2026 stood at $5.0 million, up from $4.5 million in the prior quarter.
- The five-year high for Assets was $9.0 million in Q1 2022, with the low at $2.9 million in Q4 2023.
- The 5-year median for Assets is $4.5 million (2025), against an average of $5.4 million.
- The sharpest annual moves came in 2022 and 2023: Assets jumped 828.5% in 2022, then sank 64.37% in 2023.
- Regenerative Medical Technology's Assets stood at $8.1 million in 2022, then tumbled by 64.37% to $2.9 million in 2023, then soared by 32.73% to $3.8 million in 2024, then advanced by 17.46% to $4.5 million in 2025, then climbed by 11.6% to $5.0 million in 2026.
- Business Quant data shows RMTG's Assets at $5.0 million in Q1 2026, $4.5 million in Q4 2025, and $4.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.79 Bn | 131.94 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.74 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 59.32 Bn | 54.18 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.81 Bn | 28.50 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.56 Bn | 26.40 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 19.82 Bn |
| 10 | Regenerative Medical Technology | 814,616.00 | -246,832.00 | 1.77 Mn | 5.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.01 Mn |
| Dec 31, 2025 | 4.49 Mn |
| Sep 30, 2025 | 4.52 Mn |
| Jun 30, 2025 | 4.49 Mn |
| Mar 31, 2025 | 3.98 Mn |
| Dec 31, 2024 | 3.82 Mn |
| Sep 30, 2024 | 3.23 Mn |
| Jun 30, 2024 | 3.05 Mn |
| Mar 31, 2024 | 3.08 Mn |
| Dec 31, 2023 | 2.88 Mn |
| Sep 30, 2023 | 3.31 Mn |
| Jun 30, 2023 | 7.54 Mn |
| Mar 31, 2023 | 8.07 Mn |
| Dec 31, 2022 | 8.08 Mn |
| Sep 30, 2022 | 8.23 Mn |
| Jun 30, 2022 | 8.37 Mn |
| Mar 31, 2022 | 8.96 Mn |
| Dec 31, 2021 | 9.31 Mn |
| Sep 30, 2021 | 17.07 Mn |
| Jun 30, 2021 | 10.92 Mn |